Second Line Capital, LLC

SEC CIK: 0001992879
Latest filing: Sep 2, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Second Line Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 1,125
Value: $558.8K
% of portfolio: 0.1%
Quarters held: 4; Since Q3 2025

Holdings of VRTX by Second Line Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,125	$558.8K	0.1%	−64−5.4%	Reduced	Holders
Q1 2026	1,189	$508.2K	0.1%	+45+3.9%	Added	Holders
Q4 2025	1,144	$518.6K	0.1%	+29+2.6%	Added	Holders
Q3 2025	1,115	$436.7K	0.1%	+1,115	New	Holders